Transcriptomic profile of ataxia telangiectasia cells treated for 30 days with a low dose of dexamethasone
2021
Dexamethasone administered by autologous red blood cells (RBCs) is used in clinical trials and as compassionate therapy to alleviate ataxia telangiectasia (AT) symptoms, providing long-term deliver...
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
49
References
0
Citations
NaN
KQI